Scale automated cell culture with Biolaminin ®

Biolaminin® substrates provide a consistent, chemically defined, and automation-friendly cell culture matrix. These features enable the efficient, large-scale production of billions of high-quality cells required for cell therapy.


Biolaminin enables billions of cells for therapy

Automation is essential for achieving scalable and reproducible cell culture processes across research, biomanufacturing, and regenerative medicine. However, a persistent challenge in automating cell therapy manufacturing is ensuring that cells maintain their biological consistency and functionality. Biolaminin® enables researchers to efficiently produce the billions of high-quality cells required for cell therapy by providing a consistent, chemically defined, and automation-friendly cell culture matrix.



How Biolaminin powers automated cell culture


Cell X technologies

Cell X Technologies automated cell culturing platform specializing in iPSC derivation, automated picking, stem cell maintenance, and differentiation.

Corning Ascent

Corning’s Ascent fixed bed bioreactor (FBR) for PSC scale-up (x10^9).

Terumo Quantum Flex

Terumo’s Quantum Flex hollow-fiber bioreactor for PSC scale-up (x10^7).

CellenOne

Cellenion’s cellenONE single-cell dispenser for automated cell line development.



  • Biolaminin 521 MX (MX521)

    Full-length human recombinant laminin-521

    Biolaminin 521 MX is a full-length laminin-521 substrate designed for research aiming for clinical applications.
  • Biolaminin 521 LN (LN521)

    Full-length human recombinant laminin-521

    Biolaminin 521 LN is a full-length laminin-521 substrate—the natural laminin for pluripotent stem cells, reliably facilitating ESC and iPSC self-r […]